Healthcare - Biotechnology - NASDAQ - GB
$ 0.662
3.28 %
$ 188 K
Market Cap
0.0
P/E
BALANCE SHEET
8.93 M
ASSETS
6.25 M
LIABILITIES
2.69 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
TC Biopharm (Holdings) Plc
| Current Assets | 5.7 M |
| Cash & Short-Term Investments | 2.46 M |
| Receivables | 0 |
| Other Current Assets | 3.24 M |
| Non-Current Assets | 3.23 M |
| Long-Term Investments | 0 |
| PP&E | 2.62 M |
| Other Non-Current Assets | 615 K |
| Current Liabilities | 4.75 M |
| Accounts Payable | 1.85 M |
| Short-Term Debt | 305 K |
| Other Current Liabilities | 2.6 M |
| Non-Current Liabilities | 1.5 M |
| Long-Term Debt | 2.99 M |
| Other Non-Current Liabilities | -1.5 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 2.5 | 4.8 | 1.6 | 0.7 | 1.0 |
| Short Term Investments | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0.1 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 4.1 | 0.8 | 0.8 | 0.2 | 0.2 |
| Total Current Assets | 5.7 | 7.4 | 3.9 | 2.2 | 4.2 |
| PP&E | 2.6 | 3.3 | 3.7 | 4.6 | 5.6 |
| Intangible Assets | 0.6 | 0.6 | 0.5 | 0.4 | 0.3 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 0 | 0 | 1 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 8.9 | 11.3 | 8.0 | 7.3 | 10.1 |
| LIABILITIES | |||||
| Accounts Payable | 1.8 | 0.9 | 1.4 | 0.6 | 0.6 |
| Short Term Debt | 0.3 | 1.0 | 7.6 | 0.4 | 0.4 |
| Other Current Liabilities | 2.5 | 7.3 | 9.6 | 3.1 | 2.8 |
| Total Current Liabilities | 4.8 | 9.2 | 20.6 | 4.2 | 3.9 |
| Long Term Debt | 3.0 | 1.8 | 2.1 | 2.6 | 3.0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | (1.5) | 0 | 0 | 0 | 0 |
| Total Liabilities | 6.2 | 11.0 | 24.6 | 10.6 | 12.7 |
| EQUITY | |||||
| Common Stock | 2.06 K | 0.4 | 0.2 | 0.2 | 1.8 |
| Retained Earnings | (38.8) | (33.4) | (33.5) | (19.9) | (15.4) |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | 16.7 | 16.3 | 0 |
| Total Equity | 2.7 | 0.3 | (16.6) | (3.3) | (2.5) |
| Total Liabilities and Equity | 8.9 | 11.3 | 8.0 | 7.3 | 10.1 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 30.9 K | 3.44 K | 1.95 K | 1.89 K | 1.89 K |